Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorPeking University Third Hospital
About this trial
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.
Eligibility criteria
Qualifiers
Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3);
Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography
Agree to participate in the study and sign the informed consent form.
Disqualifiers
Can not sign the informed consent form or cooperate with follow-up.
Trial design
Treatments tested in this trial
- Conservative treatment
- Antipaletet drug
- Patent Foramen Ovale Closure
Treatment groups
330 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov